On February 20, 2020 Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, reported that Pascal Touchon, the Company’s President and Chief Executive Officer, will participate at two upcoming investor conferences in March (Press release, Atara Biotherapeutics, FEB 20, 2020, View Source [SID1234554614]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen 40th Annual Health Care Conference
Fireside Chat: Monday, March 2, 2020 at 4:10 pm EST
Boston Marriott Copley Place in Boston, MA

Barclays Global Healthcare Conference
Company Presentation: Wednesday, March 11, 2020 at 11:45 am EDT
Loews Miami Beach Hotel in Miami Beach, FL

Live audio webcasts will be available by visiting the Investors & Media – News & Events section of atarabio.com. Archived replays of the webcasts will be available on the Company’s website for 14 days following the live webcasts.